Neonatal systemic pseudohypoaldosteronism type I.
10.7499/j.issn.1008-8830.2305011
- Author:
Xin-Cheng CAO
1
;
Yuan-Yuan CHEN
1
;
Ke ZHANG
1
;
Xun-Jie ZHANG
;
Lin YANG
;
Zhi-Hua LI
1
Author Information
1. Department of Neonatology, Children's Hospital of Fudan University/National Children's Medical Center, Shanghai 201102, China.
- Publication Type:Journal Article
- Keywords:
Hyperkalemia;
Hyponatremia;
Neonate;
Pseudohypoaldosteronism
- MeSH:
Infant;
Infant, Newborn;
Humans;
Male;
Pseudohypoaldosteronism/genetics*;
Hyperkalemia/etiology*;
Hyponatremia/diagnosis*;
Diagnosis, Differential
- From:
Chinese Journal of Contemporary Pediatrics
2023;25(7):774-778
- CountryChina
- Language:Chinese
-
Abstract:
An 18-day-old male infant was admitted to the hospital due to recurrent hyperkalemia for more than 10 days. The neonate had milk refusal and dyspnea. The blood gas analysis revealed recurrent hyperkalemia, hyponatremia and metabolic acidosis. Adrenocortical hormone replacement therapy was ineffective. Additional tests showed a significant increase in aldosterone levels. Family whole exome sequencing revealed that the infant had compound heterozygous in the SCNNIA gene, inherited from both parents. The infant was diagnosed with neonatal systemic pseudohypoaldosteronism type I. The infant's electrolyte levels were stabilized through treatment with sodium polystyrene sulfonate and sodium supplement. The infant was discharged upon clinical recovery. This study provides a focused description of differential diagnosis of salt-losing syndrome in infants and introduces the multidisciplinary management of neonatal systemic pseudohypoaldosteronism type I.
